Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
233.00
+7.75 (3.44%)
Feb 28, 2025, 4:00 PM CST
SHA:688506 Revenue
Sichuan Biokin Pharmaceutical had revenue of 109.83M CNY in the quarter ending September 30, 2024, with 64.78% growth. This brings the company's revenue in the last twelve months to 5.85B, up 873.42% year-over-year. In the year 2023, Sichuan Biokin Pharmaceutical had annual revenue of 561.87M, down -20.11%.
Revenue (ttm)
5.85B
Revenue Growth
+873.42%
P/S Ratio
15.81
Revenue / Employee
2.79M
Employees
2,086
Market Cap
93.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
Dec 31, 2020 | 1.01B | -193.91M | -16.07% |
Dec 31, 2019 | 1.21B | 788.57M | 188.63% |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |